Development of a reversed-phase HPLC method for determination of related impurities of Lenalidomide
In this project, we have developed a reversed phase liquid chromatography method for separation and determination of lenalidomide (LENA) and related substances by using C-8 (250×4.6 mm ID, 5 μm) HPCL column. The mobile phases A and B were phosphate buffer at Ph=3.30, and (methanol:acetonitrile)(1:5...
Main Authors: | Seyyed Amir Siadati, Meghdad Payab, Abolghasem Beheshti |
---|---|
Format: | Article |
Language: | English |
Published: |
Iranian Chemical Science and Technologies Association
2020-04-01
|
Series: | Chemical Review and Letters |
Subjects: | |
Online Access: | http://www.chemrevlett.com/article_105647_7b9118b6d63191b5e1fc99037d18bd6e.pdf |
Similar Items
-
Development of a reversed-phase HPLC method for determination of related impurities of Lenalidomide
by: Seyyed Amir Siadati, et al.
Published: (2020-04-01) -
Development and Validation of an Improved HPLC-MS/MS Method for Quantifying Total and Unbound Lenalidomide in Human Plasma
by: Suhyun Lee, et al.
Published: (2024-10-01) -
Some aspects regarding impurities profile in fipronil-HPLC method
by: Ana Csuma,, et al.
Published: (2011-12-01) -
Therapy of Angiosarcoma with Thalidomide and Lenalidomide
by: M. Jules Mattes, et al.
Published: (2021-11-01) -
Analysis of Seven Drug Related Impurities in Six Samples of Metronidazole API by High Performance Liquid Chromatography
by: Derouicha Matmour, et al.
Published: (2023-03-01)